Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research

References

• Kronenberg HM. Developmental regulation of the growth plate. Nature 2003;423:332–6
   PubMed Web of Science ®Google Scholar
• Long F, Ornitz DM. Development of the endochondral skeleton. Cold Spring Harb Perspect Biol 2013;5:a008334. doi: 10.1101/cshperspect.a008334
   PubMed Web of Science ®Google Scholar
• Colnot C, Lu C, Hu D, Helms JA. Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev Biol 2004;269:55–69
   PubMed Web of Science ®Google Scholar
• Long F, Linsenmayer TF. Regulation of growth region cartilage proliferation and differentiation by perichondrium. Development 1998;125:1067–73
   PubMed Web of Science ®Google Scholar
• Solomon L. Hereditary multiple exostosis. Am J Hum Genet 1964;16:351–63
   PubMed Web of Science ®Google Scholar
• Schmale GA, Conrad EU III, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am 1994;76:986–92
   PubMedGoogle Scholar
• Jager M, Westhoff B, Portier S, Leube B, Hardt K, Royer-Pokora B, Gossheger G, Krauspe R. Clinical outcome and genotype in patients with hereditary multiple exostoses. J Orthop Res 2007;25:1541–51
   PubMed Web of Science ®Google Scholar
• Francannet C, Cohen-Tanugi A, Le Merrer M, Munnich A, Bonaventure J, Legeai-Mallet L. Genotype-phenotype correlation in hereditary multiple exostoses. J Med Genet 2001;38:430–4
   PubMed Web of Science ®Google Scholar
• Wuyts W, Van Hul W. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat 2000;15:220–7
   PubMed Web of Science ®Google Scholar
• Lidholt K, Weinke JL, Kiser CS, Lugemwa FN, Bame KJ, Cheifetz S, Massague J, Lindahl U, Esko JD. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci USA 1992;89:2267–71
   PubMed Web of Science ®Google Scholar
• Wei G, Bai X, Gabb MM, Bame KJ, Koshy TI, Spear PG, Esko JD. Location of the glucuronosyltransferase domain in the heparan sulfate copolymerase EXT1 by analysis of Chinese hamster ovary cell mutants. J Biol Chem 2000;275:27733–40
   PubMed Web of Science ®Google Scholar
• Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem 1998;273:26265–8
   PubMed Web of Science ®Google Scholar
• McCormick C, Duncan G, Goutsos KT, Tufaro F. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA 2000;97:668–73
   PubMed Web of Science ®Google Scholar
• Bellaiche Y, The I, Perrimon N. Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature 1998;394:85–8
   PubMed Web of Science ®Google Scholar
• Hilton MJ, Gutierrez L, Martinez DA, Wells DE. EXT1 regulates chondrocyte proliferation and differentiation during endochondral bone development. Bone 2005;36:379–86
   PubMed Web of Science ®Google Scholar
• Koziel L, Kunath M, Kelly OG, Vortkamp A. Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. Dev Cell 2004;6:801–13
   PubMed Web of Science ®Google Scholar
• Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 2002;3:439–49
   PubMed Web of Science ®Google Scholar
• Naski MC, Ornitz DM. FGF signaling in skeletal development. Front Biosci 1998;3:d781–94
   PubMedGoogle Scholar
• Rapraeger AC, Guimond S, Krufka A, Olwin BB. Regulation by heparan sulfate in fibroblast growth factor signaling. Methods Enzymol 1994;245:219–40
   PubMed Web of Science ®Google Scholar
• Huegel J, Mundy C, Sgariglia F, Nygren P, Billings PC, Yamaguchi Y, Koyama E, Pacifici M. Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses. Dev Biol 2013;377:100–12
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Matsumoto K, Irie F, Fukushi J, Stallcup WB, Yamaguchi Y. Conditional ablation of the heparan sulfate-synthesizing enzyme Ext1 leads to dysregulation of bone morphogenic protein signaling and severe skeletal defects. J Biol Chem 2010;285:19227–34
   PubMed Web of Science ®Google Scholar
• Fuerer C, Habib SJ, Nusse R. A study on the interactions between heparan sulfate proteoglycans and Wnt proteins. Dev Dyn 2010;239:184–90
   PubMed Web of Science ®Google Scholar
• Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 2005;132:49–60
   PubMed Web of Science ®Google Scholar
• Mak KK, Chen MH, Day TF, Chuang PT, Yang Y. Wnt/beta-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development 2006;133:3695–707
   PubMed Web of Science ®Google Scholar
• Zak BM, Schuksz M, Koyama E, Mundy C, Wells DE, Yamaguchi Y, Pacifici M, Esko JD. Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones. Bone 2011;48:979–87
   PubMed Web of Science ®Google Scholar
• Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, Matzuk MM. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 2000;224:299–311
   PubMed Web of Science ®Google Scholar
• Stickens D, Zak BM, Rougier N, Esko JD, Werb Z. Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 2005;132:5055–68
   PubMed Web of Science ®Google Scholar
• Reijnders CM, Waaijer CJ, Hamilton A, Buddingh EP, Dijkstra SP, Ham J, Bakker E, Szuhai K, Karperien M, Hogendoorn PC, Stringer SE, Bovee JV. No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. Am J Pathol 2010;177:1946–57
   PubMed Web of Science ®Google Scholar
• Stickens D, Brown D, Evans GA. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev Dyn 2000;218:452–64
   PubMed Web of Science ®Google Scholar
• Jones KB, Piombo V, Searby C, Kurriger G, Yang B, Grabellus F, Roughley PJ, Morcuende JA, Buckwalter JA, Capecchi MR, Vortkamp A, Sheffield VC. A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci USA 2010;107:2054–9
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Irie F, Mackem S, Yamaguchi Y. A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. Proc Natl Acad Sci USA 2010;107:10932–7
   PubMed Web of Science ®Google Scholar
• Hyde G, Dover S, Aszodi A, Wallis GA, Boot-Handford RP. Lineage tracing using matrilin-1 gene expression reveals that articular chondrocytes exist as the joint interzone forms. Dev Biol 2007;304:825–33
   PubMed Web of Science ®Google Scholar
• Hilton MJ, Tu X, Long F. Tamoxifen-inducible gene deletion reveals a distinct cell type associated with trabecular bone, and direct regulation of PTHrP expression and chondrocyte morphology by Ihh in growth region cartilage. Dev Biol 2007;308:93–105
   PubMed Web of Science ®Google Scholar
• Kram V, Zcharia E, Yacoby-Zeevi O, Metzger S, Chajek-Shaul T, Gabet Y, Muller R, Vlodavsky I, Bab I. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J Cell Physiol 2006;207:784–92
   PubMed Web of Science ®Google Scholar
• Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004;303:848–51
   PubMed Web of Science ®Google Scholar
• Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002;277:44005–12
   PubMed Web of Science ®Google Scholar
• Trebicz-Geffen M, Robinson D, Evron Z, Glaser T, Fridkin M, Kollander Y, Vlodavsky I, Ilan N, Law KF, Cheah KS, Chan D, Werner H, Nevo Z. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses. Int J Exp Pathol 2008;89:321–31
   PubMed Web of Science ®Google Scholar